GRM1 and neoplasm: This analysis revealed that the metastatic Tg(Grm1) Cyld−/− cells show a reduced doubling time in comparison to Cyld-expressing cells, whereas the proliferative potential from primary tumor cells with or without CYLD expression was comparable (Fig. 2a).